文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

使用聚类分析识别脓毒症相关肝功能障碍的亚表型

IDENTIFICATION OF SUBPHENOTYPES OF SEPSIS-ASSOCIATED LIVER DYSFUNCTION USING CLUSTER ANALYSIS.
PubMed 文献 · Shock · 2022-12-23
一句话结论在MIMIC-IV与eICU中,用K-means聚类将脓毒症相关肝功能障碍分为α、β、γ、δ四个亚表型,临床特征与预后各异,δ型死亡率最低。

本研究为回顾性观察性队列研究,使用MIMIC-IV 1.0数据库作为衍生队列、eICU数据库作为验证队列,纳入ICU入科48小时内发生脓毒症相关肝功能障碍(SALD)的成人患者(年龄≥18岁),排除入ICU 48小时内死亡或转出ICU者及入ICU前肝功能异常者。在衍生队列5234例患者中,采用K-means聚类分析识别出四个SALD亚表型(α、β、γ、δ)。α型(n=1055)最严重,以休克合并多器官功能障碍(MODS)为特征;β型(n=1179)中位胆红素水平最高,基础肝病及合并凝血病比例最高;γ型(n=1661)平均年龄最高,慢性肾脏病比例最高;δ型(n=1683)28天及住院死亡率最低。验证队列中各聚类特征与衍生队列相似。作者认为这些结果可为理解SALD临床特征及相关结局、改善ICU管理提供参考。

要点

  • 在5234例SALD患者中识别出四个亚表型:α型(n=1055)最严重,以休克合并MODS为特征。
  • β型(n=1179)中位胆红素水平最高,基础肝病及合并凝血病比例最高。
  • γ型(n=1661)平均年龄最高,慢性肾脏病比例最高。
  • δ型(n=1683)28天及住院死亡率最低;δ型GGT水平显著高于其他亚表型,与胆红素模式不同。
  • 验证队列(eICU)中各聚类特征与衍生队列相似。

适用人群与场景

  • 成人患者(年龄≥18岁),在ICU入科后48小时内发生脓毒症相关肝功能障碍(SALD)。
  • 排除入ICU 48小时内死亡或转出ICU的患者,以及入ICU前肝功能异常的患者。
  • 衍生队列来自MIMIC-IV 1.0数据库,验证队列来自eICU协作研究数据库。

诊断标准与关键阈值

  • 脓毒症相关肝功能障碍(SALD)定义为ICU入科48小时内发生的肝功能障碍。
  • 使用K-means聚类分析识别亚表型。

研究设计与关键结果

  • 研究类型:回顾性观察性队列研究;衍生队列5234例,验证队列来自eICU数据库。
  • 四个亚表型:α型(n=1055)最严重,以休克合并多器官功能障碍(MODS)为特征;β型(n=1179)中位胆红素水平最高,基础肝病及合并凝血病比例最高;γ型(n=1661)平均年龄最高,慢性肾脏病比例最高;δ型(n=1683)28天及住院死亡率最低。
  • δ型GGT水平显著高于其他亚表型,与胆红素模式不同。
  • 验证队列中各聚类特征与衍生队列相似。

证据类型、等级与局限

  • 证据类型:回顾性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为这些结果可为理解SALD的临床特征及相关结局、改善ICU中SALD患者的管理提供有价值的参考。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Objectives: We attempted to identify and validate the subphenotypes of sepsis-associated liver dysfunction (SALD) using routine clinical information. Design: This article is a retrospective observational cohort study. Setting: We used the Medical Information Mart for Intensive Care IV database and the eICU Collaborative Research Database. Patients: We included adult patients (age ≥18 years) who developed SALD within the first 48 hours of intensive care unit (ICU) admission. We excluded patients who died or were discharged from the ICU within the first 48 hours of admission. Patients with abnormal liver function before ICU admission were also excluded. Measurements and Main Results: Patients in the MIMIC-IV 1.0 database served as a derivation cohort. Patients in the eICU database were used as validation cohort. We identified four subphenotypes of SALD (subphenotype α, β, γ, δ) using K-means cluster analysis in 5234 patients in derivation cohort. The baseline characteristics and clinical outcomes were compared between the phenotypes using one-way analysis of variance/Kruskal-Wallis test and the χ 2 test. Moreover, we used line charts to illustrate the trend of liver function parameters over 14 days after ICU admission. Subphenotype α (n = 1,055) was the most severe cluster, characterized by shock with multiple organ dysfunction (MODS) group. Subphenotype β (n = 1,179) had the highest median bilirubin level and the highest proportion of patients with underlying liver disease and coexisting coagulopathy (increased bilirubin group). Subphenotype γ (n = 1,661) was the cluster with the highest mean age and had the highest proportion of patients with chronic kidney disease (aged group). Subphenotype δ (n = 1,683) had the lowest 28-day and in-hospital mortality (mild group). The characteristics of clusters in the validation cohort were similar to those in the derivation cohort. In addition, we were surprised to find that GGT levels in subphenotype δ were significantly higher than in other subphenotypes, showing a different pattern from bilirubin. Conclusions: We identified four subphenotypes of SALD that presented with different clinical features and outcomes. These results can provide a valuable reference for understanding the clinical characteristics and associated outcomes to improve the management of patients with SALD in the ICU.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Miao H, Cui Z, Guo Z, et al. IDENTIFICATION OF SUBPHENOTYPES OF SEPSIS-ASSOCIATED LIVER DYSFUNCTION USING CLUSTER ANALYSIS. Shock. 2022. PMID: 36562264. doi:10.1097/SHK.0000000000002068

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。